Susquehanna International Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $247K | Buy |
36,815
+4,855
| +15% | +$32.6K | ﹤0.01% | 5290 |
|
2025
Q1 | $289K | Buy |
31,960
+19,028
| +147% | +$172K | ﹤0.01% | 5062 |
|
2024
Q4 | $224K | Buy |
+12,932
| New | +$224K | ﹤0.01% | 5151 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 6555 |
|
2023
Q2 | – | Sell |
-196,513
| Closed | -$2.85M | – | 6463 |
|
2023
Q1 | $2.85M | Buy |
196,513
+84,716
| +76% | +$1.23M | ﹤0.01% | 1586 |
|
2022
Q4 | $1.51M | Buy |
+111,797
| New | +$1.51M | ﹤0.01% | 1865 |
|